Natural genetic polymorphisms can diversify the transcriptome and proteome among individuals by altering the 38 post-transcriptional processing and modification of RNA [1] . Such regulatory variation can cause disease, 39 modify disease risk, or affect therapeutic response [2, 3]. Thus, the discovery of genetic variants that affect 40 post-transcriptional RNA regulation may reveal causal mechanisms underlying phenotypic variability and 41 disease pathogenesis in human populations [4, 5]. 42 RNA-binding proteins (RBPs) are key regulators of post-transcriptional RNA processing and modification [6]. 43
23

Abstract. 24
Gene expression is tightly regulated at the post-transcriptional level through splicing, transport, translation, and 25 decay. RNA-binding proteins (RBPs) play key roles in post-transcriptional gene regulation, and genetic variants 26 that alter RBP-RNA interactions can affect gene products and functions. We developed a computational 27 method ASPRIN (Allele-Specific Protein-RNA Interaction), that uses a joint analysis of CLIP-seq (cross-linking 28 and immunoprecipitation followed by high-throughput sequencing) and RNA-seq data to identify genetic 29 variants that alter RBP-RNA interactions by directly observing the allelic preference of RBP from CLIP-seq 30 experiments as compared to RNA-seq. We used ASPRIN to systematically analyze CLIP-seq and RNA-seq 31 data for 166 RBPs in two ENCODE (Encyclopedia of DNA Elements) cell lines. ASPRIN identified genetic 32 variants that alter RBP-RNA interactions by modifying RBP binding motifs within RNA. Moreover, through an 33 integrative ASPRIN analysis with population-scale RNA-seq data, we showed that ASPRIN can help reveal 34 potential causal variants that affect alternative splicing via allele-specific protein-RNA interactions. 35 36 37
Multiple variants of CLIP-seq (HITS-CLIP [9], PAR-CLIP [10], iCLIP [11] , and eCLIP [12] ) aimed at improving 48 library efficiency and reducing artifacts, have been used to define the RBP-RNA binding landscape of 49 hundreds of RBPs across different cell types and species. These variants of CLIP experiment are all fairly 50 similar in essence, which is cross-linking RBP and its targets for a more stringent washing of unbound RNA 51 followed by high-throughput sequencing, but due to their technical differences and biases, deliver slightly 52 different datasets, as detailed in [13] . 53
Previous studies have investigated the effects of genetic variants on post-transcriptional regulation, primarily 54 using a sequence motif-based approach. Jian et al. [14] reviewed eight bioinformatics tools that predict splice-55 altering single nucleotide variants in the human genome. These methods use information about highly 56 conserved splicing regulatory elements (5' and 3' splice sites and branch point signals) as well as auxiliary cis-57 acting elements recognized by trans-acting RBPs [14] to predict the effects of genetic variants on alternative 58 splicing. Some other recent studies used defined binding motifs of RBPs to predict variants that alter RBP-RNA 59 interactions [15, 16] . However, as RBP binding motifs are typically short (4-6 nucleotides) and degenerate, 60 methods based on RBP motifs are expected to have a low accuracy and high noise [17] . 61 mapped them separately to count reference and alternative alleles in the RNA-seq data, to alleviate systematic 86 mapping bias for the reference over the alternative alleles in CLIP-seq data compared to the RNA-seq data. 87
This procedure largely removed the bias for reference over derived alleles in the ASPRIN results 88 ( Supplementary Fig. 1 ). Finally, we tested each SNP site with at least ten reads (sum of two alleles) in both the 89 RNA-seq and CLIP-seq data for significant difference in allelic ratio via Fisher's exact test of allelic read counts 90 in RNA-seq versus CLIP-seq data. After correcting for multiple hypothesis testing, we reported SNPs with 91 corrected p-values of less than 0.1 as ASPRIN SNPs (Fig. 1a ). An example result for the HepG2 cell line is an 92 A-to-G SNP (rs115776575) in the PTPN4 gene that disrupts a highly conserved "A" nucleotide in the 93 "TGCATG" consensus motif of RBFOX2. While the allelic ratio between "A" and "G" was 1:1 in the RNA-seq 94 reads, the "G" allele represented only 10.5% of the CLIP-seq reads (Fig. 1b) , consistent with RBFOX2 binding 95 to the TGCATG motif, and that the A-to-G SNP at the fourth nucleotide position of the motif disrupts RBFOX2 96 binding. 97
ASPRIN is robust in discovering SNPs involved in allele-specific protein-RNA interactions 98
We evaluated various issues that may affect the performance of ASPRIN, such as errors arising from calling 99 variants from RNA-seq data, choice of RNA-seq protocols, and potential artifacts due to cross-linking step in 100 CLIP-seq experiments. First, since whole-genome genotype data is not available for most of the cell types with 101 CLIP-seq data, we assessed our SNP calling procedure using RNA-seq data alone. To obtain a ground truth 102 for this assessment, we called SNVs using RNA-seq data for the GM12878 cell line (SRA accessions: 103 SRR307897 and SRR307898), for which high-quality whole genome genotype data is available from the 1000 104 Genomes (1000G) Project [21] . After calling SNVs in GM12878 using our pipeline, we intersected the set of 105 heterozygous variants with known SNPs in GM12878 from the 1000G project [21] and known A-to-I RNA 106 editing sites in the RADAR database [20] to investigate the distribution of different variant types. As shown in 107 Fig. 2a , 63.2% of the called SNVs were known SNPs, and 23.8% were known RNA editing events. The 108 remaining 13.0% were unknown variants that did not match any 1000G SNPs or RADAR sites, and the 109 distribution of all 12 possible single nucleotide changes suggested that these unknown variants represented a 110 mixture of SNPs and RNA editing events ( Fig. 2a ). As shown in Fig. 2b , 89.6% of the called SNVs that were in 111 the dbSNP were also present in the 1000G data for GM12878, suggesting an upper bound of 10.4% for the 112 false discovery rate of our RNA-seq-based SNP calling procedure. Moreover, 3.6% of the called SNVs for 113 GM12878 were present in the 1000G data but not in the dbSNP, suggesting that the use of the dbSNP had a 114 minimal impact on the false negative rate of SNP identification. Collectively, our data suggest that, by using 115 dbSNP and RADAR as filters, we can obtain a set of high-confidence SNPs from our RNA-seq variant calling 116 in the absence of matching genotype data. 117
Next, we investigated issues that may affect the power of ASPRIN for calling SNPs and identifying allele-118 specific protein-RNA interactions. Specifically, the choice of RNA-seq protocol may affect the power of 119 ASPRIN depending on the binding location of a given RBP within the RNA. For instance, a cytosolic polyA+ 120 RNA-seq library would be appropriate for an RBP that predominantly binds to exons within mRNAs in the 121 cytosol, but not for an RBP that predominantly binds to introns within precursor mRNAs in the nucleus. To 122 investigate the most appropriate RNA-seq protocols and libraries, we randomly sampled equal numbers of 123 reads from polyA+ and total RNA-seq libraries of distinct subcellular fractions (nucleus, cytosol, and whole-cell) 124 from the HepG2 cell line and performed SNP calling and ASPRIN analysis on the sampled RNA-seq data. For 125 both polyA+ and total RNA-seq libraries, we called the highest number of SNPs from the nuclear RNA-seq 126 data and the lowest number of SNPs from the cytosolic RNA-seq data (Fig. 3a) . The lowest number of SNPs 127 was called from cytosolic polyA+ RNA-seq data (Fig. 3a) ; these SNPs were enriched for exonic regions within 128 UTRs (Untranslated Regions) and CDS (Coding Segments) and depleted for intronic regions within pre-129 mRNAs (Fig. 3b ). A similar trend was observed for the K562 leukemia cell line ( Supplementary Fig. 2 ). On the 130 other hand, as reads of cytosolic polyA+ RNA-seq libraries were concentrated within CDS and UTR regions, 131 such data may have better power for detecting allele-specific protein-RNA interactions of RBPs that bind 132 predominantly to exons. As expected, the nuclear fraction of the total RNA-seq library provided a much greater 133 power for ASPRIN analysis of an RBP that binds predominantly to introns (HNRNPM), while ASPRIN analyses 134 of an RBP that binds predominantly to exonic regions (YBX3) identified similar numbers of ASPRIN SNPs from 135 the cytosolic polyA+ RNA-seq library and the nuclear total RNA-seq library ( Fig. 3c ). Furthermore, after calling 136 peaks, we sorted all RBPs in both cell lines based on the ratio of exonic (CDS and UTR regions) to intronic 137 peaks. The complete distributions of peaks in different regions for all RBPs are shown in Supplementary Fig. 3  138 and we excluded RBPs for which more than 50% of peaks fell in intergenic and noncoding regions. We 139 observed a positive correlation (Pearson correlation coefficient = 0.34, p-value<0.0001) between binding of an 140 RBP to exonic regions and the relative power of identifying significant ASPRIN SNPs using cytosolic polyA+ 141 RNA-seq libraries, despite large variation among individual RBPs (Fig. 3d ). 142
Finally, we evaluated potential false positives that may arise from the cross-linking step in CLIP-seq 143 experiments. Specifically, the sequences in the CLIP-seq libraries may be altered by mutation or deletion at the 144 cross-linking site [9] [10] [11] . We noted that in the eCLIP protocol used for generating the ENCODE CLIP-seq data, 145 the majority of fragments were truncated at the cross-linking site rather than containing mutations or deletions 146 [12] . Nonetheless, we investigated this issue further by calling SNVs from the ENCODE eCLIP data and 147 comparing the distribution of variant types to that of the RNA-seq data and observed a similar distribution 148 ( Supplementary Fig. 4 ). Another possible source of artifacts is cross-linking bias that may shift the read count 149 towards specific nucleotides in the CLIP-seq data. However, 70% of ASPRIN SNPs were called significant for 150 only one RBP. Only 6% of ASPRIN SNPs were called significant for more than five RBPs. Among these SNPs, 151 the same allele was preferred by all RBPs in 87% of the SNPs, whereas in the remaining 13% different alleles 152 were preferred by different RBPs ( Supplementary Fig. 5 ). Overall, these data suggest that the fraction of 153 ASPRIN SNPs that may be attributable to CLIP-seq cross-linking bias is small. 154
ASPRIN identifies functionally relevant SNPs for different classes of RBPs 155
To assess the potential functional relevance of the ASPRIN results, we investigated the positional distribution regions for RBPs that are part of the 5' splice site machinery such as PRPF8 (22.0%), EFTUD2 (14.8%), and 170 RBM22 (11.7%). There was an enrichment of ASPRIN SNPs in coding regions for several splicing regulators 171 that primarily bind to coding exons, such as SRSF1 (40.7%) and TRA2A (29.0%). For RBFOX2, we observed 172 an enrichment of ASPRIN SNPs in both upstream and downstream proximal intronic regions (6.0% and 15.1%, 173 respectively), as we expect RBFOX2 to bind to either region to promote exon skipping or inclusion 174 respectively. The ASPRIN SNPs of HNRNP proteins were enriched in distal intronic regions and depleted in 175 coding regions, which fits that these RBPs predominantly bind to distal intronic regions. Finally, RBPs that 176 regulate mRNA stability, such as IGF2BP proteins and LIN28 showed an enrichment of ASPRIN SNPs in the 3' 177 UTR ( Fig. 4a ). We observed a similar pattern in the K562 cell line (Fig. 4b ). The numbers of ASPRIN SNPs for 178 each RBP in HepG2 and K562 are provided in Supplementary Fig. 6 . 179
ASPRIN SNPs affect RBP consensus motifs 180
To explore the potential molecular mechanisms by which ASPRIN SNPs affect protein-RNA interactions, we 181 investigated the effects of ASPRIN SNPs on RBP consensus motifs. We predicted that if an RBP binds to 182
RNAs in a highly sequence-specific manner, then variants within the conserved RBP consensus motif are likely 183 to affect binding. First, we called peaks from ENCODE CLIP-seq data using Piranha [23] and performed de 184 novo motif discovery on called peaks using Zagros [8] to obtain a 6-nucleotide consensus motif for each RBP. 185
We then calculated the information content of the consensus motif, defined as the average information content 186 of each position within the 6-nucleotide motif, as a measure of sequence specificity (see details in Methods). 187 Fig. 5a shows the RBPs in HepG2, sorted by the sequence specificity of their consensus motifs. Among all 188
RBPs, HNRNPA1 and RBFOX2 had the highest sequence specificity of their consensus motifs, and they are 189 known to bind to highly conserved AGGGAG [24] and TGCATG [25] motifs, respectively. Next, for all ASPRIN 190 SNPs of a given RBP, we obtained two sets of sequences that corresponded to the two alleles, i.e., one with 191 high binding affinity and the other with low binding affinity. Finally, we used the position weight matrix that was 192 obtained for all RBP consensus motifs by Zagros and calculated the motif scores for the two sets of sequences 193 using STORM [26] ( Supplementary Fig. 7 and Methods). Fig. 5b shows the motif scores of five RBPs with high 194 (HNRNPA1, RBFOX2), median (DKC1), and low (NCBP2, XRN2) consensus motif sequence specificity. 195
Variants in different positions within the consensus motif did not seem to affect binding equally. For example, 196 for HNRNPA1, variants in position 5 of the motif had a more significant effect on binding than did variants in 197 other positions. This result shows that not all positions in the consensus motif contribute equally to To further explore the relationship between the ASPRIN SNPs and RBP consensus motifs, we defined a motif 200 impact score for each RBP and its associated ASPRIN SNP set as the maximum difference of average motif 201 score between the two alleles with high versus low binding affinity in the window of 6 nucleotides overlapping 202 the ASPRIN SNP (see details in Supplementary Fig. 7 ). We observed a positive correlation (Pearson 203 correlation coefficient = 0.29, p-value<0.05) between the motif impact score and the sequence specificity of a 204 given RBP's consensus motif ( Fig. 5c ), suggesting that for highly sequence-specific RBPs, ASPRIN SNPs tend 205 to affect binding by altering the consensus binding motifs within the RNA. For instance, in case of HNRNPA1 206 and RBFOX2, we observed a higher motif score for alleles with higher binding affinity, while for NCBP2 and 207 XRN2, we did not observe noticeable differences in motif scores between the two alleles in any position of their 208 consensus motif (Fig. 5c ). 209
ASPRIN can help reveal causal variants affecting alternative splicing 210
Finally, we investigated whether ASPRIN can help reveal causal genetic variants that affect post-transcriptional 211 gene regulation. For this analysis, we focused on the genetic variation of alternative splicing. A series of 212 population-scale transcriptome studies have revealed widespread alternative splicing variation among human 213 individuals [4], but it remains challenging to pinpoint the causal genetic variants underlying this splicing 214 variation. To match our ASPRIN analysis of the HepG2 liver cell line, we analyzed liver RNA-seq data along 215 with matching genotype data of 71 individuals from the GTEx consortium (v6). We performed a transcriptome-216 wide scan of splicing quantitative trait loci (sQTLs) using GLiMMPS [27] and obtained ASPRIN SNPs 217 correlated with GLiMMPS sQTLs (see details in Methods). 218
Our joint ASPRIN and GLiMMPS analyses revealed candidate causal SNPs that affected alternative splicing 219 via allele-specific protein-RNA interactions. For example, GLiMMPS identified several SNPs that were 220 significantly associated with an exon-skipping event in FAM114A1, one of which was an ASPRIN SNP ( Fig.  221 6a). The genotype at the ASPRIN SNP was significantly associated with the level of exon inclusion, with the 222 GG and AA genotypes showing the highest and lowest levels of exon inclusion, respectively (Fig. 6b ). The 223 ASPRIN analysis indicated that the G allele was associated with significantly greater binding by the splicing 224 factor SRSF9 ( Fig. 6b ), while the A allele disrupted binding at this highly conserved "G" nucleotide at the fourth 225 position of the SRSF9 consensus motif (Fig. 6b ). Collectively, these data suggest that the G-to-A SNP 226 disrupted the binding of the splicing activator SRSF9, leading to reduced inclusion of the FAM114A1 exon. 227
Similarly, we identified an ASPRIN SNP for the splicing factor SF3B4, which was significantly associated with 228 an alternative 3' splice site event in ARL6IP4 ( Fig. 6c, d ). This C-to-T SNP was located 7 nucleotides upstream 229 of the intron-exon boundary and disrupted a highly conserved 'C' nucleotide at the fourth position of the SF3B4 230 consensus motif. This was reflected by a much lower percentage of the T allele in the SF3B4 CLIP-seq data 231 than in the RNA-seq data and increased usage of an upstream cryptic 3' splice site for the TT genotype ( Fig.  232 6c, d). Overall, our results show that ASPRIN can help pinpoint causal variants within a window of SNPs that 233 are correlated with levels of alternative splicing and in high linkage disequilibrium with each other. 234
We further associated ASPRIN SNPs with genome-wide association study (GWAS) SNPs [28] . Specifically, we 235 used the linkage disequilibrium (LD) map of a CEU population to calculate LD correlations between all ASPRIN 236 SNPs and SNPs associated with diseases and traits in the NHGRI GWAS catalog [28] . Supplementary Tables  237   1 and 2 
Methods 257
Calling variants from RNA-seq data 258
The total RNA-seq data for HepG2 whole-cell preparations from two different labs (ENCSR468ION and 259 ENCSR181ZGR), a HepG2 cytosolic fraction (ENCSR862HPO), a HepG2 nuclear fraction (ENCSR061SFU), 260 K562 whole-cell preparations from two different labs (ENCSR000AEN and ENCSR885DVH), a K562 cytosolic 261 fraction (ENCSR860DWK), and a K562 nuclear fraction (ENCSR040YBR) were downloaded from the 262 ENCODE website (https://www.encodeproject.org/). 263
The GATK Best Practices workflow for SNP and indel calling on RNA-seq data was used with minor 264 modifications [18] . Briefly, the data sets were mapped using STAR v.2.5.2a [30] , and total RNA-seq data from 265 all fractions and all labs were merged to make one large RNA-seq data set for each cell line. (2) a second round of adaptor cutting was performed to control for double ligation events; (3) the 282 resulting reads were mapped to the human-specific version of Repbase [33] using STAR 2.5.2a [30] to remove 283 repetitive elements and other repetitive reads, as well as to control for spurious artifacts from rRNA. Repbase 284 was downloaded from: http://www.girinst.org/downloads/; (4) Reads mapped to repetitive regions were filtered 285 out of the resulting output from STAR; (5) PCR duplicates were further removed using random-mers, which are 286 provided in the names of the reads; (6) Second (paired-end) reads were used to perform peak-calling using 287 Piranha [23], with a bin size of 1nt. We considered significant peaks to be those that had a corrected p-value of 288 less than 0.01 (command lines in Supplementary Information). Mapping and peak calling statistics for RBPs in 289
HepG2 and K562 cell lines are given in Supplementary Tables 4 and 5 Hochberg method and reported SNPs with q-value < 0.1 as significantly differentially bound, or "ASPRIN 298 SNPs". 299
Assessing the robustness of ASPRIN 300
To measure the error associated with the used variant filtering method, RNA-seq data sets for the GM12878 301 cell line were downloaded from SRA (SRR307897 and SRR307898) and the complete genotype for this cell 302 line from the 1000G website [21] . We performed variant calling as described above and intersected the set of 303 called variants with 1000G SNPs, dbSNP, and RADAR. 304
To investigate the choice of RNA-seq protocol and how it may affect the power of ASPRIN, in addition to the 305 total RNA-seq data, we also downloaded polyA+ mRNA-seq data for the same cell lines, fractions, and 306 laboratories: HepG2 whole-cell preparations from two different labs (ENCSR985KAT and ENCSR561FEE), a 307
HepG2 cytosolic fraction (ENCSR931WGT), a HepG2 nuclear fraction (ENCSR058OSL), K562 whole-cell 308 preparations from two different labs (ENCSR000AEO and ENCSR545DKY), a K562 cytosolic fraction 309 (ENCSR384ZXD), and a K562 nuclear fraction (ENCSR530NHO). To normalize for read number and length, 310 we sampled n number of reads from all of these data sets, ten times, where n was the minimum number of 311 reads among these data sets. The RNA-seq libraries that had 100-nucleotide reads (from Brenton Graveley's 312 lab) were also truncated to 50 nucleotides, to have the same read length as the RNA-seq libraries with 50-313 nucleotide reads (from Eric Lecuyer's lab). We then called variants from all these data sets and compared the 314 number of called variants and the regions in which these variants were located. We also ran the ASPRIN 315 pipeline on all CLIP data sets with these ten subsampled RNA-seq data sets using only cytosolic polyA+ 316 mRNA-seq and nuclear total RNA-seq, to compare the number of ASPRIN SNPs that can be called using 317 these two distinct RNA-seq sets representing different RNA species and subcellular fractions. 318
To investigate the cross-linking bias and its potential effects on our analysis, for any ASPRIN SNP that was 319 associated with at least one of the 75 RBPs in the HepG2 cell line, we counted for how many RBPs this SNP 320 was: (1) called significant with preference for the reference allele; (2) called significant with preference for the 321 alternative allele; (3) not called significant; and (4) not present in enough reads to pass the filters for the 322 ASPRIN analysis. 323
ASPRIN SNP enrichment or depletion in genomic regions 324
We measured the enrichment of ASPRIN SNPs in different genomic regions using Fisher's exact test. For RBP 325
x and region r, we counted (1) the number of ASPRIN SNPs for x in r, and (2) the rest of ASPRIN SNPs for x. 326
In addition, for the background, we counted (3) the number of ASPRIN SNPs in r for the rest of the RBPs and 327 (4) the number of ASPRIN SNPs in any region except r for the rest of the RBPs. Then, we used Fisher's exact 328 test to measure the significance of enrichment or depletion of ASPRIN SNPs in region r for RBP x compared to 329 the average expectation. 330
Measuring RBP sequence specificity 331
We determined the sequence specificity of RBPs as the information content of the motif obtained by de novo 332 motif discovery in the high-quality binding sites as defined by the Piranha peak caller [23] . For each RBP, 333 peaks output was obtained using Piranha. Then the genomic region (intron, 5' UTR, coding segment, 3' UTR, 334 noncoding RNA, and intergenic sequence) containing each peak was assigned to them. All peaks in noncoding 335 or intergenic regions were filtered out and the highest peak in each gene was selected as the representative 336 peak of that RBP binding to the gene. Finally, top 1000 peaks based on the corrected p-value reported by 337 Piranha were selected as the set of high-quality peaks. Zagros [8] was then used for de novo motif discovery, 338
using sequence and secondary structure information. The parameters were window size 6 and top 10 motifs (-339 w 6 -n 10), and we selected the top motif reported by Zagros as the discovered motif for that RBP. Information 340 content for each RBP consensus motif is obtained by taking the average information content over all positions 341 within the consensus sequence and for each position defined by Shannon's entropy. RBPs with consensus 342 sequences that had more information content were considered to have higher sequence specificity. 343
Motif enrichment analysis 344
Motif enrichment analysis was done using the STORM software [26]. As described above the top 6-nucleotide 345 motif discovered by Zagros in top 1000 peaks for each RBP was used as the consensus motif for that RBP. 346 STORM can use the motif position weight matrix output from Zagros directly and calculate the enrichment of 347 that motif in the set of input sequences. 348
For each SNP, a sequence of 11 nucleotides centered at the SNP (windows containing all 6-mer positions in 349 the genome that include the SNP) was extracted. Then for each sequence we flipped the center nucleotide, the 350 SNP, to the alternative allele. Therefore, for each RBP, two sets of sequences are formed, that are pairwise 351 identical, except for the center position that contains two alleles of the SNP. One set contains the alleles with 352 low affinity binding and the other contains the alleles with high affinity binding. Then STORM was run using the 353 corresponding consensus motif for each RBP in two sets of sequences for the said RBP to assess the 354 difference in motif score. Parameters for STORM can be set in a way to find the top occurrence of a motif per 355 sequence (-n 1 -q) in single stranded mode (-S) for RNA (command lines in Supplementary Information). For 356 each RBP we only considered SNPs that have positive scores in both high and low binding affinity sequences 357 to filter out SNPs occurring outside the binding site. For each SNP the maximum motif score among all 6 358 possible windows on the high binding affinity sequence and its corresponding motif score in the low binding 359 affinity sequence were selected to produce the boxplots of motif scores for each RBP in each position of the 360 motif. We also defined a motif impact score for each RBP and its associated ASPRIN SNP set as the 361 maximum difference in average motif score between the two alleles with high versus low binding affinity in the 362 window of 6 nucleotides overlapping the ASPRIN SNP ( Supplementary Fig. 7) . on the splicing event. The false discovery rate (FDR) was estimated using a permutation procedure to obtain 371 the null hypothesis. We performed this permutation ten times, recorded the minimum p-value for each site over 372 all cis SNPs in each permutation, and used this set of p-values as the empirical null distribution. Using an FDR 373 threshold of 10%, we calculated the p-value cutoff t such that P(p 0 < t)/P(p 1 < t) = 0.1, where P(p 0 < t) is the 374 fraction of expected p-values from the null distribution less than t and P(p 1 < t) is the fraction of observed p-375 values less than t from the real data. For each splicing event, the sQTLs are defined as the SNPs that have p-376 values less than the cutoff. The linkage disequilibrium (LD) with all the ASPRIN SNPs was calculated and used 377 for selecting only the exons that had sQTLs in high LD with ASPRIN SNPs (r 2 > 0.8). The LD map was created 378 using a CEU population [28] . Exons for cases in which the ASPRIN SNP is near the exon were further filtered 379 with the criteria that the ASPRIN SNP is within a window of 500 nucleotides around the alternative splicing 380 event. The windows were defined for each alternative splicing event as follows: (1) skipped exon: 500 381 nucleotides into the introns on each side of the skipped exon; (2) mutually exclusive exons: 500 nucleotides 382 into the introns on each side of two mutually exclusive exons; (3,4) alternative 5' or 3' splice sites: 500 383 nucleotides into the introns on each side of the longer exon; and (5) intron retention: 500 nucleotides into the 384 exons on each side of the retained intron. The numbers of exons in each type of alternative splicing event that 385 pass the filters are given in Supplementary Table 6 . 386
GWAS signals 387
23,444 GWAS SNPs with p-values < 10 -5 were downloaded from the NHGRI GWAS catalog [28] and PLINK 388 v1.08p [34] was used to calculate the LD between ASPRIN SNPs and GWAS SNPs on the LD map that was 389 created using a CEU population [28] . SNPs in high LD (r 2 > 0.8) with GWAS SNPs were reported as GWAS-390 correlated ASPRIN SNPs. 391
Software availability 392
The ASPRIN source code is available under GNU General Public License version 3.0 and can be downloaded 393 The plots are shown for a GLiMMPS sQTL involving alternative 3' splice site usage in ARL6IP4, along with an 522 ASPRIN SNP with differential binding of SF3B4 that is in high LD with the sQTL. 523 AUH  RPS3  EIF3D  EIF3H  RPS5  SF3B4  U2AF2  SF3A3  RBM5  U2AF1  BUD13  SMNDC1  SND1  PPIG  SRSF1  TRA2A  SRSF9  RBM15  SRSF7  RBFOX2  TIA1  CSTF2T  PTBP1  HNRNPK  CSTF2  HNRNPU  HNRNPA1  HNRNPL  TAF15  QKI  HNRNPC  SFPQ  HNRNPM  SUGP2  PRPF8  EFTUD2  RBM22  CDC40  IGF2BP1  IGF2BP3  LARP4  LIN28B  PCBP2  DDX6  ILF3  SUPV3L1  XRN2  FAM120A  GRSF1  HNRNPUL1  XPO5  LSM11  FKBP4  DGCR8  NOL12  FASTKD2  DKC1  TROVE2  DHX30  AGGF1  BCCIP  DDX55  DDX59  FUBP3  GRWD1  GTF2F1  LARP7  NKRF  SLTM  SUB1  TBRG4 DDX3X  NCBP2  RPS3  AUH  RPS5  EWSR1  EIF4G2  RPS11  SF3B4  U2AF2  GPKOW  BUD13  U2AF1  SMNDC1  FMR1  SRSF1  SRSF7  RBM15  TRA2A  SND1  HNRNPL  CPSF6  PTBP1  TARDBP  TAF15  HNRNPK  HNRNPU  NONO  DDX42  RBFOX2  ZRANB2  KHDRBS1  AKAP8L  GEMIN5  QKI  CSTF2T  HNRNPM  TIA1  HNRNPA1  KHSRP  SF3B1  PRPF8  RBM22  EFTUD2  UPF1  IGF2BP1  PUM2  IGF2BP2  YBX3  DDX6  LIN28B  FXR2  LARP4  SERBP1  ILF3  FXR1  XRN2  TNRC6A  FAM120A  HNRNPUL1  LSM11  SLBP  DROSHA  DGCR8  ZNF622  FASTKD2  SBDS  TROVE2  GNL3  NPM1  DDX24  DHX30  NSUN2  MTPAP  AARS  PUS1  FTO  AGGF1  DDX55  GTF2F1  HLTF  LARP7  METAP2  PPIL4  RBM27  SAFB2  SLTM  TBRG4  UCHL5  XRCC6 QKI  PRPF8  HNRNPL  SRSF9  FUBP3  SRSF1  PTBP1  HNRNPC  SF3B4  XRCC6  HNRNPK  ILF3  TIA1  PPIG  U2AF2  U2AF1  XPO5  GRWD1  BCCIP  CSTF2  IGF2BP3  HNRNPU  SUPV3L1  TAF15  RPS5  HNRNPM  BUD13  TRA2A  SUGP2  LIN28B  RBM5  GRSF1  RBM22  SRSF7  HNRNPUL1  DKC1  DDX55  PCBP2  SF3A3  SFPQ  LARP4  SMNDC1  RBM15  AUH  EFTUD2  SUB1  FAM120A  DDX59  IGF2BP1  LSM11  CSTF2T  CDC40  LARP7  SND1  AGGF1  UCHL5  DHX30  NKRF  NOL12  FKBP4  TROVE2  DDX3X  EIF3D  TBRG4  GTF2F1  DDX6  DGCR8  SLTM  FASTKD2  EIF3H  RPS3  NCBP2 
C C T C T C A A T G G A G A C G T G A C
